atorvastatin has been researched along with betadex in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boerner, JL; Bohin, N; Ge, Y; Irwin, ME; Mueller, KL | 1 |
Lv, HX; Waddad, AY; Zhang, ZH; Zhou, JP | 1 |
Chen, B; Chen, J; Gao, W; He, B; Liu, M; Wan, S; Wu, H; Yang, K | 1 |
Dhanaraj, P; Israel, EVMV; Paulraj, MS; Sudha, N; Yousuf, S | 1 |
Antony, EJ; Enoch, IV; Paulraj, MS; Ramasamy, S; Shibu, A | 1 |
5 other study(ies) available for atorvastatin and betadex
Article | Year |
---|---|
Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib.
Topics: Atorvastatin; Benzylamines; beta-Cyclodextrins; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cholesterol; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; ErbB Receptors; Female; Gefitinib; Heptanoic Acids; Humans; Lovastatin; Membrane Microdomains; Phosphorylation; Protein Kinase Inhibitors; Protein Transport; Proto-Oncogene Proteins c-akt; Pyrroles; Quinazolines; Thiophenes | 2011 |
Preparation, physicochemical characteristics and bioavailability studies of an atorvastatin hydroxypropyl-beta-cyclodextrin complex.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Algorithms; Analysis of Variance; Animals; Area Under Curve; Atorvastatin; beta-Cyclodextrins; Biological Availability; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Delayed-Action Preparations; Electrochemistry; Excipients; Hardness; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Magnetic Resonance Spectroscopy; Models, Molecular; Pyrroles; Rats; Solubility; Spectroscopy, Fourier Transform Infrared; Tablets; X-Ray Diffraction | 2012 |
Dual pH and temperature responsive hydrogels based on β-cyclodextrin derivatives for atorvastatin delivery.
Topics: Atorvastatin; beta-Cyclodextrins; Delayed-Action Preparations; Drug Carriers; Hydrogels; Hydrogen-Ion Concentration; Methacrylates; Temperature | 2016 |
On the accessibility of surface-bound drugs on magnetic nanoparticles. Encapsulation of drugs loaded on modified dextran-coated superparamagnetic iron oxide by β-cyclodextrin.
Topics: Atorvastatin; beta-Cyclodextrins; Dextrans; Drug Compounding; Magnetite Nanoparticles; Magnetometry; Microscopy, Electron, Scanning; Pharmaceutical Preparations; Photoelectron Spectroscopy; Raloxifene Hydrochloride; Silybin; Silymarin; Spectrometry, Fluorescence; Surface Properties; X-Ray Diffraction | 2016 |
Loading of atorvastatin and linezolid in β-cyclodextrin-conjugated cadmium selenide/silica nanoparticles: A spectroscopic study.
Topics: Atorvastatin; beta-Cyclodextrins; Cadmium Compounds; Drug Carriers; Dynamic Light Scattering; Fluorescence Resonance Energy Transfer; Linezolid; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Selenium Compounds; Silicon Dioxide; Spectrophotometry, Infrared | 2016 |